Predicted to enable DNA binding activity; DNA-directed DNA polymerase activity; and protein heterodimerization activity. Predicted to be part of CHRAC. Predicted to be active in nucleus. Is expressed in several structures, including alimentary system; eye; genitourinary system; hemolymphoid system gland; and nervous system. Orthologous to human CHRAC1 (chromatin accessibility complex subunit 1). [provided by Alliance of Genome Resources, Apr 2022]